adrenergic-blocking drugs
TRANSCRIPT
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
CHAPTER 18CHAPTER 18
Adrenergic-Blocking DrugsAdrenergic-Blocking Drugs
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Adrenergic BlockersAdrenergic Blockers
Bind to adrenergic receptors, but inhibit or Bind to adrenergic receptors, but inhibit or block stimulation of the sympathetic nervous block stimulation of the sympathetic nervous system (SNS) system (SNS)
(alpha)-blockers and (alpha)-blockers and (beta)-blockers(beta)-blockers
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Adrenergic Blockers (cont’d)Adrenergic Blockers (cont’d)
Have the opposite effect of adrenergic drugsHave the opposite effect of adrenergic drugs Also known as:Also known as:
Adrenergic antagonists Adrenergic antagonists SympatholyticsSympatholytics -blockers, -blockers, -blockers, or -blockers, or --––blockersblockers
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Adrenergic Blockers (cont’d)Adrenergic Blockers (cont’d)
Sympatholytics inhibit—or LYSE—Sympatholytics inhibit—or LYSE—sympathetic stimulationsympathetic stimulation
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Adrenergic Blockers (cont’d)Adrenergic Blockers (cont’d)
Classified by the type of adrenergic receptor Classified by the type of adrenergic receptor they blockthey block11 and and 22 receptors receptors 11 and and 22 receptors receptors
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Drug Effects and IndicationsDrug Effects and Indications
Ergot alkaloids (Ergot alkaloids (-blockers)-blockers) Constrict dilated arterioles in the brainConstrict dilated arterioles in the brain Used to treat vascular headaches (migraines)Used to treat vascular headaches (migraines) Stimulate uterine contractions (oxytocics) and Stimulate uterine contractions (oxytocics) and
induce local vasoconstrictioninduce local vasoconstriction Used to control postpartum bleedingUsed to control postpartum bleeding
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Drug Effects and Indications Drug Effects and Indications (cont’d)(cont’d)
-blockers-blockers Cause both arterial and venous dilation, reducing Cause both arterial and venous dilation, reducing
peripheral vascular resistance and BPperipheral vascular resistance and BP Used to treat hypertensionUsed to treat hypertension Effect on receptors on prostate gland and bladder Effect on receptors on prostate gland and bladder
decreased resistance to urinary outflow, thus reducing decreased resistance to urinary outflow, thus reducing urinary obstruction and relieving effects of BPHurinary obstruction and relieving effects of BPH
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Drug Effects and Indications Drug Effects and Indications (cont’d)(cont’d)
-blockers (cont'd)-blockers (cont'd) Used to control and prevent hypertension in patients Used to control and prevent hypertension in patients
with pheochromocytomawith pheochromocytoma Phentolamine Phentolamine
Quickly reverses the potent vasoconstrictive effects of Quickly reverses the potent vasoconstrictive effects of extravasated vasopressors such as norepinephrine or extravasated vasopressors such as norepinephrine or epinephrineepinephrine
Restores blood flow and prevents tissue necrosisRestores blood flow and prevents tissue necrosis
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
-Blockers: Adverse Effects-Blockers: Adverse Effects
Body SystemBody System Adverse EffectsAdverse Effects
CardiovascularCardiovascular Palpitations, orthostaticPalpitations, orthostatichypotension, tachycardia, hypotension, tachycardia,
edema, dysrhythmias, chest painedema, dysrhythmias, chest pain
CNSCNS Dizziness, headache, drowsiness,Dizziness, headache, drowsiness,anxiety, depression, vertigo,anxiety, depression, vertigo,weakness, numbness, fatigueweakness, numbness, fatigue
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
-Blockers: Adverse Effects (cont’d)-Blockers: Adverse Effects (cont’d)
Body SystemBody System Adverse EffectsAdverse Effects
GastrointestinalGastrointestinal Nausea, vomiting, diarrhea,Nausea, vomiting, diarrhea,constipation, abdominal painconstipation, abdominal pain
OtherOther Incontinence, nosebleed,Incontinence, nosebleed,tinnitus, dry mouth, pharyngitis,tinnitus, dry mouth, pharyngitis,rhinitisrhinitis
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Common Common -Blockers-Blockers
ergotamine tartrate (Ergostat)ergotamine tartrate (Ergostat) phenoxybenzamine HCl (Dibenzyline)phenoxybenzamine HCl (Dibenzyline) phentolamine (Regitine)phentolamine (Regitine) prazosin (Minipress)prazosin (Minipress) tolazoline (Priscoline)tolazoline (Priscoline)
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
-Blockers-Blockers
Block stimulation of Block stimulation of receptors in receptors in the SNSthe SNS
Compete with norepinephrine and Compete with norepinephrine and epinephrineepinephrine
Selective and nonselective Selective and nonselective -blockers-blockers Nonselective Nonselective -blockers block both -blockers block both 11 and and 22
receptorsreceptors
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
ReceptorsReceptors
1 1 receptorsreceptors Located primarily on the heartLocated primarily on the heart -blockers selective for these receptors -blockers selective for these receptors
are called cardioselective are called cardioselective -blockers-blockers
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Receptors (cont’d)Receptors (cont’d)
2 2 receptorsreceptors Located primarily on smooth muscles Located primarily on smooth muscles
of bronchioles and blood vesselsof bronchioles and blood vessels
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Mechanism of ActionMechanism of Action
Cardioselective (Cardioselective (11)) Reduces SNS stimulation of the heartReduces SNS stimulation of the heart Decreases heart rateDecreases heart rate Prolongs SA node recoveryProlongs SA node recovery Slows conduction rate through the AV nodeSlows conduction rate through the AV node Decreases myocardial contractility, thus Decreases myocardial contractility, thus
reducing myocardial oxygen demandreducing myocardial oxygen demand
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Mechanism of Action (cont’d)Mechanism of Action (cont’d)
Nonselective (Nonselective (11 and and 22)) Effects on heart:Effects on heart: Same as cardioselectiveSame as cardioselective Bronchioles:Bronchioles: Constriction, resulting in Constriction, resulting in
narrowing of airways and narrowing of airways and shortness of breathshortness of breath
Blood vessels:Blood vessels: VasoconstrictionVasoconstriction Other effectsOther effects
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
IndicationsIndications
Antiangina:Antiangina: Decreases demand forDecreases demand formyocardial oxygenmyocardial oxygen
Cardioprotective:Cardioprotective: Inhibits stimulation fromInhibits stimulation fromcirculatingcirculating
catecholaminescatecholamines Class II antidysrhythmics Class II antidysrhythmics
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Indications (cont’d)Indications (cont’d)
AntihypertensiveAntihypertensive Some are used to treat heart failureSome are used to treat heart failure Treatment of migraine headachesTreatment of migraine headaches Glaucoma (topical use)Glaucoma (topical use)
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Adverse Effects: Adverse Effects: -Blockers-Blockers
Body SystemBody System Adverse EffectsAdverse Effects
BloodBlood Agranulocytosis, thrombocytopeniaAgranulocytosis, thrombocytopenia
CardiovascularCardiovascular AV block, bradycardia, AV block, bradycardia, heart failure, peripheral vascularheart failure, peripheral vascular
insufficiencyinsufficiency
CNSCNS Dizziness, mental depression,Dizziness, mental depression,lethargy, hallucinationslethargy, hallucinations
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Adverse Effects: Adverse Effects: Adrenergic-Blocking DrugsAdrenergic-Blocking Drugs
-blockers-blockersBody SystemBody System Adverse EffectsAdverse Effects
GastrointestinalGastrointestinal Nausea, dry mouth, vomiting,Nausea, dry mouth, vomiting,diarrhea, cramps, ischemic diarrhea, cramps, ischemic colitiscolitis
OtherOther Impotence, rash, alopecia,Impotence, rash, alopecia,bronchospasmbronchospasm
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
-Blockers: Examples-Blockers: Examples
acebutolol (Sectral)acebutolol (Sectral) carvedilol (Coreg)carvedilol (Coreg) labetalol (Trandate)labetalol (Trandate) metoprolol (Lopressor)metoprolol (Lopressor)
atenolol (Tenormin)atenolol (Tenormin) esmolol (Brevibloc)esmolol (Brevibloc) sotalol (Betapace)sotalol (Betapace) propranolol (Inderal)propranolol (Inderal)
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Adrenergic-Blocking Drugs: Adrenergic-Blocking Drugs: Nursing ImplicationsNursing Implications
Assess for allergies and history of COPD, Assess for allergies and history of COPD, hypotension, cardiac dysrhythmias, hypotension, cardiac dysrhythmias, bradycardia, heart failure, or other bradycardia, heart failure, or other cardiovascular problemscardiovascular problems Any preexisting condition that might be Any preexisting condition that might be
exacerbated by the use of these drugs might be a exacerbated by the use of these drugs might be a contraindicationcontraindication to their use to their use
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Adrenergic-Blocking Drugs: Adrenergic-Blocking Drugs: Nursing Implications (cont’d)Nursing Implications (cont’d)
Remember that Remember that -blockers may precipitate -blockers may precipitate hypotensionhypotension
Remember that some Remember that some -blockers may -blockers may precipitate bradycardia, hypotension, precipitate bradycardia, hypotension, heart block, heart failure, and heart block, heart failure, and bronchoconstrictionbronchoconstriction
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Adrenergic-Blocking Drugs: Adrenergic-Blocking Drugs: Nursing Implications (cont’d)Nursing Implications (cont’d)
Avoid OTC medications because of possible Avoid OTC medications because of possible interactionsinteractions
Possible drug interactions may occur with:Possible drug interactions may occur with: Antacids (aluminum hydroxide type)Antacids (aluminum hydroxide type) Antimuscarinics/anticholinergicsAntimuscarinics/anticholinergics Diuretics and cardiovascular drugsDiuretics and cardiovascular drugs Neuromuscular blocking drugsNeuromuscular blocking drugs Oral hypoglycemic drugsOral hypoglycemic drugs
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Adrenergic-Blocking Drugs: Adrenergic-Blocking Drugs: Nursing Implications (cont’d)Nursing Implications (cont’d)
Encourage patients to take medications Encourage patients to take medications as prescribedas prescribed
These medications should never be These medications should never be stopped abruptlystopped abruptly
Report constipation or the development of Report constipation or the development of any urinary hesitancy or bladder distentionany urinary hesitancy or bladder distention
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Adrenergic-Blocking Drugs: Adrenergic-Blocking Drugs: Nursing Implications (cont’d)Nursing Implications (cont’d)
Teach patients to change positions slowly to Teach patients to change positions slowly to prevent or minimize postural hypotensionprevent or minimize postural hypotension
Avoid caffeine (excessive irritability)Avoid caffeine (excessive irritability) Avoid alcohol ingestion and hazardous Avoid alcohol ingestion and hazardous
activities until blood levels become stableactivities until blood levels become stable Patients should notify their physician if Patients should notify their physician if
palpitations, dyspnea, nausea, or vomiting palpitations, dyspnea, nausea, or vomiting occursoccurs
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
-Blocking Drugs: -Blocking Drugs: Nursing ImplicationsNursing Implications
Rebound hypertension or chest pain may occur if Rebound hypertension or chest pain may occur if this medication is discontinued abruptlythis medication is discontinued abruptly
Patients should notify their physician if they Patients should notify their physician if they become ill and unable to take medicationbecome ill and unable to take medication
Inform patients that they may notice a decrease Inform patients that they may notice a decrease in their tolerance for exercise; dizziness and in their tolerance for exercise; dizziness and fainting may occur with increased activity. Notify fainting may occur with increased activity. Notify the physician if these problems occurthe physician if these problems occur
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
-Blocking Drugs: -Blocking Drugs: Nursing Implications (cont’d)Nursing Implications (cont’d)
Patients should report the following to Patients should report the following to
their physician:their physician: Weight gain of more than 2 pounds in 1 day or 5 lb Weight gain of more than 2 pounds in 1 day or 5 lb
within 1 weekwithin 1 week Edema of the feet or anklesEdema of the feet or ankles Shortness of breathShortness of breath Excessive fatigue or weaknessExcessive fatigue or weakness Syncope or dizzinessSyncope or dizziness
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Adrenergic-Blocking Drugs: Adrenergic-Blocking Drugs: Nursing ImplicationsNursing Implications
Monitor for adverse effectsMonitor for adverse effects
Monitor for therapeutic effectsMonitor for therapeutic effects Decreased chest pain in patients with anginaDecreased chest pain in patients with angina Return to normal BP and PReturn to normal BP and P Other specific effects, depending on the useOther specific effects, depending on the use